The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

Tallal Younis; D. Rayson; C. Skedgel

doi:10.3747/co.v18i6.810

The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e288-e296
Journal	Current Oncology
Volume	18
Issue number	6
DOIs	https://doi.org/10.3747/co.v18i6.810
Publication status	Published - 2011

ASJC Scopus Subject Areas

Oncology

Keywords

Ac chemotherapy
Adjuvant therapy
Breast cancer
Chemotherapy
Cost-utility analysis
Tc chemotherapy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3747/co.v18i6.810

Cite this

@article{0083708d9f7f4440979fc50c028a8908,

title = "The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer",

keywords = "Ac chemotherapy, Adjuvant therapy, Breast cancer, Chemotherapy, Cost-utility analysis, Tc chemotherapy",

author = "Tallal Younis and D. Rayson and C. Skedgel",

year = "2011",

doi = "10.3747/co.v18i6.810",

language = "English",

volume = "18",

pages = "e288--e296",

journal = "Current Oncology",

issn = "1198-0052",

publisher = "Multimed Inc.",

number = "6",

}

TY - JOUR

T1 - The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

AU - Younis, Tallal

AU - Rayson, D.

AU - Skedgel, C.

PY - 2011

Y1 - 2011

KW - Ac chemotherapy

KW - Adjuvant therapy

KW - Breast cancer

KW - Chemotherapy

KW - Cost-utility analysis

KW - Tc chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=82955169580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955169580&partnerID=8YFLogxK

U2 - 10.3747/co.v18i6.810

DO - 10.3747/co.v18i6.810

M3 - Article

AN - SCOPUS:82955169580

SN - 1198-0052

VL - 18

SP - e288-e296

JO - Current Oncology

JF - Current Oncology

IS - 6

ER -

The cost-utility of adjuvant chemotherapy using docetaxel and cyclophosphamide compared with doxorubicin and cyclophosphamide in breast cancer

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this